SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-21-001482
Filing Date
2021-01-19
Accepted
2021-01-19 17:23:03
Documents
6
Period of Report
2021-01-19

Document Format Files

Seq Description Document Type Size
1 PREM14A nc10018681x3_prem14a.htm PREM14A 2461336
2 logo_pwpx2.jpg GRAPHIC 22584
3 nc10018681x3_pc01x1.jpg GRAPHIC 794199
4 nc10018681x3_pc02x1.jpg GRAPHIC 1024315
5 nc10018681x3_pc03x1.jpg GRAPHIC 947812
6 nc10018681x3_pc04x1.jpg GRAPHIC 819000
  Complete submission text file 0001140361-21-001482.txt   7430210
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36200 | Film No.: 21536408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances